Is concomitant aspirin helping novel oral anticoagulants? Focus on apixaban.
作者信息
DiNicolantonio James J, Tomek Ales, Meier Pascal, O'Keefe James H, D'Ascenzo Fabrizio, Cerrato Enrico, Chatterjee Saurav, Biondi-Zoccai Giuseppe
机构信息
Mid America Heart Institute, St. Luke's Hospital , Kansas City, Missouri , USA.
Department of Neurology , Charles University in Prague, 2nd Faculty of Medicine, University Hospital Motol , Prague , Czech Republic.
出版信息
Open Heart. 2014 Sep 12;1(1):e000134. doi: 10.1136/openhrt-2014-000134. eCollection 2014.
Abstract
摘要
相似文献
1
Is concomitant aspirin helping novel oral anticoagulants? Focus on apixaban.
Open Heart. 2014 Sep 12;1(1):e000134. doi: 10.1136/openhrt-2014-000134. eCollection 2014.
2
Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial.
Eur Heart J. 2014 Jan;35(4):224-32. doi: 10.1093/eurheartj/eht445. Epub 2013 Oct 20.
3
Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
Adv Ther. 2012 Jun;29(6):491-507. doi: 10.1007/s12325-012-0026-8. Epub 2012 Jun 7.
4
Stroke prevention in patients with atrial fibrillation in France: comparative cost-effectiveness of new oral anticoagulants (apixaban, dabigatran, and rivaroxaban), warfarin, and aspirin.
J Med Econ. 2014 Aug;17(8):587-98. doi: 10.3111/13696998.2014.923891. Epub 2014 May 29.
5
Cost-effectiveness of apixaban for stroke prevention in non-valvular atrial fibrillation in Saudi Arabia.
Ann Saudi Med. 2019 Jul-Aug;39(4):265-278. doi: 10.5144/0256-4947.2019.265. Epub 2019 Aug 5.
6
Association of Intracranial Hemorrhage Risk With Non-Vitamin K Antagonist Oral Anticoagulant Use vs Aspirin Use: A Systematic Review and Meta-analysis.
JAMA Neurol. 2018 Dec 1;75(12):1511-1518. doi: 10.1001/jamaneurol.2018.2215.
7
Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From AUGUSTUS.
Circulation. 2020 May 19;141(20):1618-1627. doi: 10.1161/CIRCULATIONAHA.120.046534. Epub 2020 Mar 29.
8
Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation.
Eur Heart J. 2014 Jul 21;35(28):1897-906. doi: 10.1093/eurheartj/ehu006. Epub 2014 Feb 9.
9
Initial 3-weeks' Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) followed by Clopidogrel alone in high-risk patients with Acute Non-Disabling Cerebrovascular Events (ADANCE): study protocol for a randomized controlled trial.
Clin Drug Investig. 2014 Nov;34(11):755-61. doi: 10.1007/s40261-014-0228-8.
10
Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.
PLoS One. 2016 Aug 3;11(8):e0160064. doi: 10.1371/journal.pone.0160064. eCollection 2016.
本文引用的文献
1
Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial.
Eur Heart J. 2014 Jan;35(4):224-32. doi: 10.1093/eurheartj/eht445. Epub 2013 Oct 20.
2
Dabigatran or warfarin for the prevention of stroke in atrial fibrillation? A closer look at the RE-LY trial.
Expert Opin Pharmacother. 2012 Jun;13(8):1101-11. doi: 10.1517/14656566.2012.671809. Epub 2012 Mar 22.
3
Apixaban versus warfarin in patients with atrial fibrillation.
N Engl J Med. 2011 Sep 15;365(11):981-92. doi: 10.1056/NEJMoa1107039. Epub 2011 Aug 27.
4
Combination warfarin-ASA therapy: which patients should receive it, which patients should not, and why?
Thromb Res. 2011 Jun;127(6):513-7. doi: 10.1016/j.thromres.2011.02.010. Epub 2011 Mar 31.
5
Apixaban in patients with atrial fibrillation.
N Engl J Med. 2011 Mar 3;364(9):806-17. doi: 10.1056/NEJMoa1007432. Epub 2011 Feb 10.
6
Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism.
Ann Intern Med. 2010 May 4;152(9):578-89. doi: 10.7326/0003-4819-152-9-201005040-00008.
7
Aspirin dosing for the prevention and treatment of ischemic stroke: an indication-specific review of the literature.
Ann Pharmacother. 2010 May;44(5):851-62. doi: 10.1345/aph.1M346. Epub 2010 Apr 13.
8
Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study).
Am J Cardiol. 2007 Nov 1;100(9):1419-26. doi: 10.1016/j.amjcard.2007.06.034. Epub 2007 Aug 17.
9
Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis.
Ann Intern Med. 2003 Dec 2;139(11):893-900. doi: 10.7326/0003-4819-139-11-200312020-00007.
10
Stroke Prevention in Atrial Fibrillation Study. Final results.
Circulation. 1991 Aug;84(2):527-39. doi: 10.1161/01.cir.84.2.527.
Zotero 插件